Kagolanu D^1,2,3, Levine I^1,2,3, Katz S^1,2,3. Gastroenterol Hepatol (N Y). 2019 Jan;15(1):28-34.

Author information

1 Dr Kagolanu is a medical resident in the Department of Internal Medicine at Nassau University Medical Center in East Meadow, New York.

2 Dr Levine is a medical resident in the Department of Internal Medicine at NYU Langone Health in New York, New York.

3 Dr Katz is a professor in the Department of Gastroenterology at NYU Langone Health.

Abstract

The role of vitamin D has long been discussed in many chronic diseases, and its significance in inflammatory boweldisease has recently gained attention. This article reviews vitamin D homeostasis, the involvement of vitamin D in the pathophysiology of inflammatory bowel disease, and vitamin D deficiency as a result of inflammatory boweldisease. In addition, this article explores the possibility of age, specifically in the elderly population, as a risk factor for developing vitamin D deficiency in patients with inflammatory bowel disease.